The effect of smoking on lung function: A clinical study of adult-onset asthma

European Respiratory Journal

Volumn 48, Issue 5, 2016, Pages 1298-1306

  Tommola, Minna ^a   Ilmarinen, Pinja ^a   Tuomisto, Leena E ^a   Haanpää, Jussi ^a   Kankaanranta, Terhi ^b   Niemelä, Onni ^a   Kankaanranta, Hannu ^a,c  

^a SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^b Police University College   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT; AGE DISTRIBUTION; ARTICLE; ASTHMA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FINLAND; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SMOKING HABIT; SPIROMETRY; WEIGHT GAIN; AGED; LUNG; LUNG FUNCTION TEST; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHENOTYPE; TREATMENT OUTCOME; VITAL CAPACITY;

ADULT; AGE OF ONSET; AGED; ASTHMA; FEMALE; FINLAND; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; RESPIRATORY FUNCTION TESTS; SMOKING; SPIROMETRY; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84994301828     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00850-2016     Document Type: Article

References (43)

1. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012; 18: 716-725.
2. De Nijs SB, Venekamp LN, Bel EH. Adult-onset asthma: is it really different? Eur Respir Rev 2013; 22: 44-52.
3. Ilmarinen P, Tuomisto LE, Kankaanranta H. Phenotypes, risk factors and mechanisms of adult-onset asthma. Mediators Inflamm 2015; 2015: 514868.
4. Tuomisto LE, Ilmarinen P, Kankaanranta H. Prognosis of new-onset asthma diagnosed at adult age. Respir Med 2015; 109: 944-954.
5. Cerveri I, Cazzoletti L, Corsico AG, et al. The impact of cigarette smoking on asthma: a population-based international cohort study. Int Arch Allergy Immunol 2012; 158: 175-183.
6. Polosa R, Russo C, Caponnetto P, et al. Greater severity of new onset asthma in allergic subjects who smoke: a 10-year longitudinal study. Respir Res 2011; 12: 16.
7. Eisner MD, Iribarren C. The influence of cigarette smoking on adult asthma outcomes. Nicotine Tob Res 2007; 9: 53-56.
8. Thomson NC, Chaudhuri R, Heaney LG, et al. Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma. J Allergy Clin Immunol 2013; 131: 1008-1016.
9. Kauppi P, Kupiainen H, Lindqvist A, et al. Long-term smoking increases the need for acute care among asthma patients: a case control study. BMC Pulm Med 2014; 14: 119.
10. Boulet L-P, Lemière C, Archambault F, et al. Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation. Chest 2006; 129: 661-668.
11. Chalmers GW, Macleod KJ, Thomson L, et al. Smoking and airway inflammation in patients with mild asthma. Chest 2001; 120: 1917-1922.
12. Chalmers GW, MacLeod KJ, Little SA, et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002; 57: 226-230.
13. Dijkstra A, Vonk JM, Jongepier H, et al. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax 2006; 61: 105-110.
14. Lazarus SC, Chinchilli VM, Rollings NJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007; 175: 783-790.
15. Tomlinson JE, McMahon AD, Chaudhuri R, et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005; 60: 282-287.
16. Nakamura K, Nagata C, Fujii K, et al. Cigarette smoking and the adult onset of bronchial asthma in Japanese men and women. Ann Allergy Asthma Immunol 2009; 102: 288-293.
17. Polosa R, Knoke JD, Russo C, et al. Cigarette smoking is associated with a greater risk of incident asthma in allergic rhinitis. J Allergy Clin Immunol 2008; 121: 1428-1434.
18. Westerhof GA, Vollema EM, Weersink EJ, et al. Predictors for the development of progressive severity in new-onset adult asthma. J Allergy Clin Immunol 2014; 134: 1051-1056.
19. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194-1200.
20. James AL, Palmer LJ, Kicic E, et al. Decline in lung function in the Busselton health study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med 2005; 171: 109-114.
21. Aanerud M, Carsin A-E, Sunyer J, et al. Interaction between asthma and smoking increases the risk of adult airway obstruction. Eur Respir J 2015; 45: 635-643.
22. Apostol GG, Jacobs DR Jr, Tsai AW, et al. Early life factors contribute to the decrease in lung function between ages 18 and 40: the Coronary Artery Risk Development in Young Adults study. Am J Respir Crit Care Med 2002; 166: 166-172.
23. Colak Y, Afzal S, Nordestgaard BG, et al. Characteristics and prognosis of never-smokers and smokers with asthma in the Copenhagen General Population Study. A prospective cohort study. Am J Respir Crit Care Med 2015; 192: 172-181.
24. Hancox RJ, Gray AR, Poulton R, et al. The effect of cigarette smoking on lung function in young adults with asthma. Am J Respir Crit Care Med 2016; 194: 276-284.
25. Grol MH, Gerritsen J, Vonk JM, et al. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. Am J Respir Crit Care Med 1999; 160: 1830-1837.
26. Ulrik CS, Backer V, Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax 1992; 47: 14-18.
27. Kankaanranta H, Ilmarinen P, Kankaanranta T, et al. Seinäjoki Adult Asthma Study (SAAS): a protocol for a 12-year real-life follow-up study of new-onset asthma diagnosed at adult age and treated in primary and specialised care. NPJ Prim Care Respir Med 2015; 25: 15042.
28. Haahtela T, Klaukka T, Koskela K, et al. Asthma programme in Finland: a community problem needs community solutions. Thorax 2001; 56: 806-814.
29. Viljanen AA, Halttunen PK, Kreus KE, et al. Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest Suppl 1982; 159: 5-20.
30. Amelink M, de Groot JC, de Nijs SB, et al. Severe adult-onset asthma: a distinct phenotype. J Allergy Clin Immunol 2013; 132: 336-341.
31. Drummond MB, Hansel NN, Connett JE, et al. Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185: 1301-1306.
32. O'Byrne PM, Lamm CJ, Busse WW, et al. The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma. Chest 2009; 136: 1514-1520.
33. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1: 1645-1648.
34. Csikesz NG, Gartman EJ. New developments in the assessment of COPD: early diagnosis is key. Int J Chron Obstruct Pulmon Dis 2014; 9: 277-286.
35. Tantucci C, Modina D. Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis 2012; 7: 95-99.
36. Kim HB, Eckel SP, Kim JH, et al. Exhaled NO: determinants and clinical application in children with allergic airway disease. Allergy Asthma Immunol Res 2016; 8: 12-21.
37. Miranda C, Busacker A, Balzar S, et al. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004; 113: 101-108.
38. Kankaanranta H, Kauppi P, Tuomisto LE, et al. Emerging comorbidities in adult asthma: risks, clinical associations, and mechanisms. Mediators Inflamm 2016; 2016: 3690628.
39. Bai TR, Vonk JM, Postma DS, et al. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J 2007; 30: 452-456.
40. Sharma S, Litonjua AA, Tantisira KG, et al. Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program. J Allergy Clin Immunol 2008; 122: 921-928.
41. Global Initiative for Asthma and Global Initiative for Chronic Obstructive Lung Disease. Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS). 2015. www.ginasthma.org Date last accessed: September 21, 2015.
42. Kankaanranta H, Harju T, Kilpeläinen M, et al. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the Finnish guidelines. Basic Clin Pharmacol Toxicol 2015; 116: 291-307.
43. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2015. www.ginasthma.org Date last accessed: September 21, 2015.